Covid-19 pneumonia in a kidney transplant recipient successfully treated with Tocilizumab and Hydroxychloroquine.

Link to article at PubMed

Covid-19 pneumonia in a kidney transplant recipient successfully treated with Tocilizumab and Hydroxychloroquine.

Am J Transplant. 2020 Apr 23;:

Authors: Fontana F, Alfano G, Mori G, Amurri A, Lorenzo T, Ballestri M, Leonelli M, Facchini F, Damiano F, Magistroni R, Cappelli G

Abstract
Coronavirus disease 2019 (Covid-19) pneumonia has been poorly reported in solid-organ transplanted patients; prognosis is uncertain and best management unclear. We describe the case of a 61-year-old kidney transplant recipient with several co-morbidities who was hospitalized and later received a diagnosis of Covid-19 pneumonia; the infection was successfully managed with the use of hydroxychloroquine and a single administration of Tocilizumab, after immunosuppression reduction; the patient did not require mechanical ventilation. During the rapid spread of SARS-CoV-2 pandemic, transplant clinicians should be readily informed about new cases of Covid-19 pneumonia in solid-organ transplant recipients, with focus on therapeutic strategies employed and their outcome.

PMID: 32324331 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.